Janus Henderson Glb Life Scn H1 GBP
Pricing frequency
Daily
Dealing cut off time
17:00
Type
OEIC
Yield
0.04%
NAV
£31.61
Ongoing charge
0.86%
Latest actual NAV date
18-04-2024
ISIN
IE00BRJ9D748
UCITS
Yes
This fund can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/03/2024 | % of assets |
|---|---|
| Eli Lilly and Co | 7.04 |
| UnitedHealth Group Inc | 5.84 |
| Novo Nordisk A/S | 5.12 |
| Merck & Co Inc | 3.62 |
| AstraZeneca PLC | 3.59 |
| AbbVie Inc | 3.36 |
| Sanofi SA | 2.49 |
| Vertex Pharmaceuticals Inc | 2.31 |
| Boston Scientific Corp | 2.31 |
| Abbott Laboratories | 2.26 |
Investment objective
The Fund’s investment objective is long-term growth of capital. It pursues its objective by investing at least 80% of its net asset value in equities (also known as company shares) located anywhere in the world and selected for their growth potential. The Fund will invest at least 80% of its net asset value in companies that the relevant Sub-Investment Adviser believes have a life sciences orientation. Generally speaking, the “life sciences” relate to maintaining or improving quality of life. Thus, companies with a “life sciences orientation” include companies engaged in research, development, production or distribution of products or services related to health and personal care, medicine or pharmaceuticals. Such companies may also include companies that the relevant Sub-Investment Adviser believes have growth potential mainly as a result of particular products, technology, patents or other market advantages in the life sciences.
Morningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.